CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Interferon alpha-2 as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia.
Authors
BACCARANI M
COMMITTEE:
+7 more
D. RUSSO
FANIN R
FIACCHINI M
THE ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA. WRITING
TURA S
ZACCARIA A
ZUFFA E
Publication date
1 January 1994
Publisher
Massachusetts Medical Society:860 Winter Street:Waltham, MA 02451:(800)843-6356, (781)893-3800, EMAIL:
[email protected]
, INTERNET: http://www.massmed.org/, Fax: (781)647-5785, (781)893-7368
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Archivio istituzionale della ricerca - Università di Brescia
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:iris.unibs.it:11379/6651
Last time updated on 12/11/2016